Jiabing Wang

This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Cancer Therapeutics. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Astrazeneca Ab. Active years: 2000-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiabing Wang. Retrieved from https://idiyas.com/inventor/jiabing-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 2)

% Patents Active = 57.1

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 161(Granted Patents)

Location History:

Lansdale, PA (US) (2000 - 2004)
Shanghai, CN (2015 - 2017)
Chalfont, PA (US) (2002 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

patents

6. 1 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2022

Loading Chart...

Areas of Expertise:

ErbB Receptor Inhibitors

Quinazoline Inhibitors

AKT Activity Inhibitors

Androgen Receptor Modulators

Integrin Receptor Antagonists

Benzazepinone Compounds

4-Azasteroid Derivatives

Substituted Triazoles

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11447492 - ERBB receptor inhibitors (2022-09-20),

2. 10822334 - ErbB receptor inhibitors (2020-11-03),

3. 9718806 - Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor (2017-08-01),

4. 9375432 - Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor (2016-06-28),

5. 9066979 - Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor (2015-06-30),

6. 8691825 - Inhibitors of AKT activity (2014-04-08),

7. 8536193 - Inhibitors of AKT activity (2013-09-17),

8. 8207169 - Substituted [1,2,4]triazolo[4',3′:1,6]pyrido[2,3-b]pyrazines of the formula D (2012-06-26),

9. 8008317 - Inhibitors of akt activtiy (2011-08-30),

10. 7763659 - N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators (2010-07-27),

11. 7629367 - [object Object] (2009-12-08),

12. 7625919 - 4-azasteroid derivatives as androgen receptor modulators (2009-12-01),

13. 7482359 - Androgen receptor modulators (2009-01-27),

14. 7402577 - Androstane 17-beta-carboxamides as androgen receptor modulators (2008-07-22),

15. 7268153 - N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators (2007-09-11),

Title: The Innovative Journey of Jiabing Wang

Introduction: Jiabing Wang, a talented inventor hailing from Chalfont, PA (US), has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Wang's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics in healthcare, a revolutionary renewable energy storage system, and a novel cybersecurity solution for IoT devices.

Career Highlights: With a background in electrical engineering and computer science, Wang has worked for over two decades in various tech companies, leading research and development teams to create innovative solutions. He holds multiple patents in the fields of AI, renewable energy, and cybersecurity.

Collaborations: Wang has collaborated with top universities and research institutions to further his inventions, partnering with experts in the field to bring his ideas to life. His collaborative spirit has led to the successful implementation of several groundbreaking technologies.

Conclusion: Jiabing Wang's passion for innovation and his dedication to pushing the boundaries of technology have solidified his place as a respected inventor in the industry. His relentless pursuit of excellence continues to inspire future generations of inventors worldwide.

Profile summary based on public USPTO records.